Clinical Trial Update: Combination Chemotherapy and Bevacizumab With or Without Bevacizumab Maintenance Therapy in Treating Patients With Metastatic Colorectal Cancer [Phase 2, Phase 3]

View source ↗

Summary

A study evaluating combination chemotherapy with bevacizumab, with or without maintenance bevacizumab, in metastatic colorectal cancer (Phase 2/3).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• Bevacizumab (bevacizumab)

Snippet

Sponsor: Federation Francophone de Cancerologie Digestive | Conditions: Colorectal Cancer | Phase 2, Phase 3 | Status: COMPLETED